The World Health Organization (WHO) reported its projections for the 53 countries in Europe to have another 700,000 deaths from Covid-19 by spring 2022, which would bring the total to more than 2 million in the region.
If you are not happy with the results below please do another search
50 search results for:
Top U.S. infectious disease official Dr. Anthony Fauci said on November 23 the vast majority of Americans who have been vaccinated against Covid-19 should receive a booster shot, and that an additional dose could eventually become the country’s standard for determining who is fully vaccinated.
A federal jury on November 23 found that pharmacy chain operators CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the U.S. drug crisis.
The Biden administration asked a federal appeals court on November 23 to lift a court-ordered stay on a sweeping workplace Covid-19 vaccine rule to avoid serious harm to public health, or alternatively to allow a masking-and-testing requirement.
The U.S. Food and Drug Administration approved Takeda Pharmaceutical Co. Ltd.’s drug Livtencity for a common type of viral infection occurring in patients after organ transplant.
The World Health Organization said on November 23 an additional 700,000 people could die from Covid-19 in Europe by March 2022, taking the total to above 2.2 million, as the WHO urged people to get vaccinated and to have booster shots.
The Food and Drug Administration cleared the way for Tonix Pharmaceuticals to begin a Phase II study of the company’s therapeutic candidate, which intends to prevent migraine headaches.
The U.S. Food and Drug Administration greenlit Aadi Bioscience’s Fyarro for treating a rare and aggressive form of cancer that disproportionately affects women.
Glympse Bio has developed a liquid biopsy with the potential to diagnose and monitor non-alcoholic steatohepatitis (NASH) with significantly higher accuracy and less invasiveness than needle biopsies, according to a late-breaking presentation at the American Association for the Study of Liver Disease (AASLD) annual The Liver Meeting.
New discovery facilities have been launched in the biotech space by AstraZeneca, BeiGene, and NeuExcell Therapeutics.